These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1482148)

  • 1. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.
    Brouqui P; Raoult D
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2799-803. PubMed ID: 1482148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.
    Klein MB; Nelson CM; Goodman JL
    Antimicrob Agents Chemother; 1997 Jan; 41(1):76-9. PubMed ID: 8980758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Ehrlichia sennetsu to antibiotics.
    Brouqui P; Raoult D
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1593-6. PubMed ID: 2221869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Ehrlichia phagocytophila.
    Horowitz HW; Hsieh TC; Aguero-Rosenfeld ME; Kalantarpour F; Chowdhury I; Wormser GP; Wu JM
    Antimicrob Agents Chemother; 2001 Mar; 45(3):786-8. PubMed ID: 11181361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis.
    Dawson JE; Ewing SA
    Am J Vet Res; 1992 Aug; 53(8):1322-7. PubMed ID: 1510307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An update on human ehrlichiosis].
    Corcaci DC
    Rev Med Chir Soc Med Nat Iasi; 1998; 102(3-4):65-8. PubMed ID: 10756846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis.
    Buller RS; Arens M; Hmiel SP; Paddock CD; Sumner JW; Rikhisa Y; Unver A; Gaudreault-Keener M; Manian FA; Liddell AM; Schmulewitz N; Storch GA
    N Engl J Med; 1999 Jul; 341(3):148-55. PubMed ID: 10403852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro studies on the susceptibility of ovine strains of Anaplasma phagocytophilum to antimicrobial agents and to immune serum.
    Woldehiwet Z
    J Comp Pathol; 2010; 143(2-3):94-100. PubMed ID: 20170925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Case of Ehrlichia chaffeensis Infection, Taiwan.
    Peng SH; Yang SL; Ho YN; Chen HF; Shu PY
    Emerg Infect Dis; 2019 Nov; 25(11):2141-2143. PubMed ID: 31625863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?
    Bakken JS; Dumler JS; Chen SM; Eckman MR; Van Etta LL; Walker DH
    JAMA; 1994 Jul; 272(3):212-8. PubMed ID: 8022040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibilities of Ehrlichia risticii to eight antibiotics.
    Rikihisa Y; Jiang BM
    Antimicrob Agents Chemother; 1988 Jul; 32(7):986-91. PubMed ID: 3142345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.
    Breitschwerdt EB; Hegarty BC; Hancock SI
    J Clin Microbiol; 1998 Sep; 36(9):2645-51. PubMed ID: 9705408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehrlichia chaffeensis in child, Venezuela.
    Martínez MC; Gutiérrez CN; Monger F; Ruiz J; Watts A; Mijares VM; Rojas MG; Triana-Alonso FJ
    Emerg Infect Dis; 2008 Mar; 14(3):519-20. PubMed ID: 18325283
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal Monocytic Ehrlichiosis in Woman, Mexico, 2013.
    Sosa-Gutierrez CG; Solorzano-Santos F; Walker DH; Torres J; Serrano CA; Gordillo-Perez G
    Emerg Infect Dis; 2016 May; 22(5):871-4. PubMed ID: 27088220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization.
    Perez M; Rikihisa Y; Wen B
    J Clin Microbiol; 1996 Sep; 34(9):2133-9. PubMed ID: 8862572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ehrlichiosis.
    Weinstein RS
    Am Fam Physician; 1996 Nov; 54(6):1971-6. PubMed ID: 8900357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the antigenic constituents of Ehrlichia chaffeensis.
    Chen SM; Dumler JS; Feng HM; Walker DH
    Am J Trop Med Hyg; 1994 Jan; 50(1):52-8. PubMed ID: 8304572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded Geographic Distribution and Clinical Characteristics of Ehrlichia ewingii Infections, United States.
    Harris RM; Couturier BA; Sample SC; Coulter KS; Casey KK; Schlaberg R
    Emerg Infect Dis; 2016 May; 22(5):862-5. PubMed ID: 27089171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.
    Barnewall RE; Ohashi N; Rikihisa Y
    Infect Immun; 1999 May; 67(5):2258-65. PubMed ID: 10225882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of susceptibility of Ehrlichia canis to imidocarb dipropionate in vitro.
    Kelly PJ; Matthewman LA; Brouqui P; Raoult D
    J S Afr Vet Assoc; 1998 Jun; 69(2):55-6. PubMed ID: 9760397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.